Emla (EMLA) Lyfjaplástur 25+25 mg/plástur Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

emla (emla) lyfjaplástur 25+25 mg/plástur

aspen pharma trading limited - lidocainum inn; prilocainum inn - lyfjaplástur - 25+25 mg/plástur

Humulin NPH KwikPen Stungulyf, dreifa í áfylltum lyfjapenna 100 a.e./ml Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

humulin nph kwikpen stungulyf, dreifa í áfylltum lyfjapenna 100 a.e./ml

eli lilly danmark a/s - insulin human - stungulyf, dreifa í áfylltum lyfjapenna - 100 a.e./ml

Mometason Apofri Nefúði, dreifa 50 míkróg/skammt Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

mometason apofri nefúði, dreifa 50 míkróg/skammt

evolan pharma ab - mometasonum fúróat - nefúði, dreifa - 50 míkróg/skammt

Certican Tafla 0,75 mg Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

certican tafla 0,75 mg

novartis healthcare a/s - everolimusum inn - tafla - 0,75 mg

Certican Tafla 0,5 mg Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

certican tafla 0,5 mg

novartis healthcare a/s - everolimusum inn - tafla - 0,5 mg

Certican Tafla 0,25 mg Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

certican tafla 0,25 mg

novartis healthcare a/s - everolimusum inn - tafla - 0,25 mg

Nasonex Nefúði, dreifa 50 míkróg/skammt Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

nasonex nefúði, dreifa 50 míkróg/skammt

n.v. organon* - mometasonum fúróat - nefúði, dreifa - 50 míkróg/skammt